Lipoprotein Genotype and Longevity in Humans
Author Information
Author(s): Atzmon Gil, Rincon Marielisa, Schechter Clyde B, Shuldiner Alan R, Lipton Richard B, Bergman Aviv, Barzilai Nir
Primary Institution: Albert Einstein College of Medicine
Hypothesis
Polymorphisms in genes related to lipoprotein metabolism influence exceptional longevity in humans.
Conclusion
Homozygosity for the APOC3 −641C allele is associated with a favorable lipoprotein profile, cardiovascular health, insulin sensitivity, and longevity.
Supporting Evidence
- The prevalence of the APOC3 −641C allele was higher in centenarians and their offspring compared to controls.
- Centenarians with the favorable genotype had lower serum levels of APOC3.
- Those with the APOC3 −641C genotype showed greater insulin sensitivity.
- Hypertension was less prevalent among individuals with the APOC3 −641C genotype.
- Survival analysis indicated a significant survival advantage for those with the APOC3 −641C genotype.
Takeaway
Having certain genes related to fat metabolism can help people live longer and healthier lives.
Methodology
The study genotyped 66 polymorphisms in 36 candidate genes related to cardiovascular disease in centenarians, their offspring, and age-matched controls.
Potential Biases
Potential for selection bias due to the specific recruitment of centenarians and their offspring.
Limitations
The study is limited to a specific population (Ashkenazi Jews), which may affect the generalizability of the findings.
Participant Demographics
213 centenarians (157 females, 56 males), 216 offspring (122 females, 94 males), and 258 controls.
Statistical Information
P-Value
p = 0.0001 for centenarians vs controls
Confidence Interval
[95% CI, 0.2–3.6]
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website